Alpha Square Group S’s Edwards Lifesciences EW Stock Holding History

Alpha Square Group S’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-26,500	Closed	-$2.19M	–	44
2022 Q3	$2.19M	Buy	+26,500	New	+$2.55M	0.99%	26

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Alpha Square Group S's EW Position: Q4 2022 in Review

Alpha Square Group S sold out of Edwards Lifesciences (EW) in Q4 2022, closing a stake of 26,500 shares — an estimated $2.19M sold.

Alpha Square Group S first reported a position in EW in Q3 2022 and held it in 1 quarter. The position peaked at $2.19M in Q3 2022. 1,228 funds tracked by Wall St. Rank hold EW as of Q4 2022.

Alpha Square Group S reported no remaining Edwards Lifesciences position as of Q4 2022 after selling out during the quarter.
Alpha Square Group S sold 26,500 Edwards Lifesciences shares in Q4 2022, an estimated $2.19M.
Alpha Square Group S first reported a position in Edwards Lifesciences in Q3 2022 and held it in 1 quarter.
Alpha Square Group S's Edwards Lifesciences position peaked at $2.19M in Q3 2022.
1,228 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2022.

Based on Alpha Square Group S's 13F filing for Q4 2022, filed 14 Feb 2023.